Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Compare the efficacy and safety of two doses of oral valacyclovir in immunocompromised
patients with uncomplicated herpes zoster.
II. Compare quality of life, pain, and medical resource utilization in patients treated with
these 2 regimens.